Gemcovac-OM, the booster vaccine for Omicron from Emcure's subsidiary Gennova, had recently received the nod from the office of the Drug Control General of India (DCGI) for Emergency Use Authorization (EUA). Individuals above 18 years and who have received either Covaxin or Covishield as primary vaccination can take it as a booster for active immunization for the prevention of COVID-19.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/BY0MTSk
via IFTTT
0 comments:
Post a Comment